Skip to main content

Cytogenetic and FISH Techniques in Myeloid Malignancies

  • Protocol
Myeloid Leukemia

Part of the book series: Methods In Molecular Medicineā„¢ ((MIMM,volume 125))

  • 869 Accesses

Summary

Chromosome analysis is an essential part of the diagnostic testing of myeloid malignancies. Good chromosome preparations are essential for a complete cytogenetic analysis. This means plentiful metaphase spreads with well-spread crisply banded chromosomes. To achieve such a result, several variables, including the growth rate of the leukemic cells, are critical. The method described in this chapter has been extensively tested and should produce reasonable results from most cases. Fluorescence in situ hybridization (FISH) is less influenced by sample variation and as a result may be obtained from either metaphase spreads or interphase cells. Moreover, FISH is capable of describing chromosome rearrangements at the gene level, rather than at the gross level shown by conventional cytogenetics. It does not, however, provide information on genetic rearrangements other than at the specific target site of the probe used, unlike conventional cytogenetics. Thus, these two techniques complement each other and are both now essential elements of chromosome analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goldman J. M. and Melo J. V. (2003) Chronic myeloid leukemia-advances in biology and new approaches to treatment. N. Engl. J. Med. 349, 1451ā€“1464.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  2. Byrd J. C., Mrozek K., Dodge R. K., Carroll A. J., Edwards C. G., Arthur D. C., et al. Cancer and Leukemia Group B (CALGB 8461). (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100, 4325ā€“4336.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  3. Greenberg P., Cox C., LeBeau M. M., Fenaux P., Morel P., Sanz G., et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89, 2079ā€“2088.

    PubMedĀ  CASĀ  Google ScholarĀ 

  4. Webber L. M. and Garson O. M. (1983) Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet. Cytogenet. 8, 123ā€“132.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  5. Barch M. J., Knutsen T., and Spurbeck J. L. (1997) The AGT Cytogenetics Laboratory Manual, third ed. Philadelphia: Lippincott-Raven Publishers.

    Google ScholarĀ 

  6. Frohling S., Skelin S., Liebisch C., Scholl C., Schlenk R. F., Dohner H., et al. Acute Myeloid Leukemia Study Group, Ulm. (2002) Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J. Clin. Oncol. 20, 2480ā€“2485.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  7. Sinclair P. B., Nacheva E. P., Leversha M., Telford N., Chang J., Reid A., et al. (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95, 738ā€“744.

    PubMedĀ  CASĀ  Google ScholarĀ 

  8. Andreeff M. and Pinkel D. (1999) Introduction to Fluorescence in situ Hybridization. Wiley-Liss New York.

    Google ScholarĀ 

  9. Mitelman F. (ed) (1995) An International System for Human Cytogenetic Nomenclature. S. Karger, Basel.

    Google ScholarĀ 

  10. Rooney D. E. (2001) Human Cytogenetics: Malignancy and Acquired Abnormalities, third ed. Oxford University Press, Oxford, UK.

    Google ScholarĀ 

  11. Mascarello J. T., Brothman A. R., Davison K., Dewald G. W., Herrman M., McCandless D., et al. Cytogenetics Resource Committee of the College of American Pathologists and American College of Medical Genetics. (2002) Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probes. Arch. Pathol. Lab. Med. 126, 1458ā€“1462.

    PubMedĀ  CASĀ  Google ScholarĀ 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2006 Humana Press Inc.

About this protocol

Cite this protocol

Campbell, L.J. (2006). Cytogenetic and FISH Techniques in Myeloid Malignancies. In: Iland, H., Hertzberg, M., Marlton, P. (eds) Myeloid Leukemia. Methods In Molecular Medicineā„¢, vol 125. Humana Press. https://doi.org/10.1385/1-59745-017-0:13

Download citation

  • DOI: https://doi.org/10.1385/1-59745-017-0:13

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-485-2

  • Online ISBN: 978-1-59745-017-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics